롱

Corona Stock : Ready for 60% !

업데이트됨

genOway is a biotechnology company specializing in the design and development of molecular, cellular and animal research models with high added value for the biopharmaceutical, chemical, agrochemical and agrifood industries as well as for academic research. genOway is a leading company in its market. It bases its development on the combination of a broad and exclusive technological platform and strong intellectual property combining patents and operating licenses. genOway has concluded numerous commercial contracts with the leaders of the pharmaceutical industry (BMS, Janssen, Novartis, Pfizer, etc.), and with the most prestigious academic research centers (King's College and University of Manchester in England, Harvard, Caltech and the National Institute of Health in the United States, the Pasteur Institute in France, the NGFN and the Max Planck Institute in Germany, etc.).

액티브 트레이드

Target : €7
SL : €3.43

노트

Current Market Cap: €24M
2019 Turn-over : €9.4M
2022 Turn-over target : €30M

The potential is enormous!

노트

SL reached! I bought 3.31 €.